{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:48:13Z","timestamp":1755794893553,"version":"3.44.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,16]]},"DOI":"10.7759\/cureus.90229","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T16:21:01Z","timestamp":1755361261000},"source":"Crossref","is-referenced-by-count":0,"title":["Serum Lipid Abnormalities in Pre-malignant and Malignant Lesions of the Gall Bladder"],"prefix":"10.7759","author":[{"given":"Lovely","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Fiza Mustaqueem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taj","family":"Mohd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshan","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashutosh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Keshav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler RS","year":"2002","unstructured":"Sandler RS, Everhart JE, Donowitz M, et al.. The burden of selected digestive diseases in the United States. Gastroenterology. 2002, 122:1500-11. 10.1053\/gast.2002.32978","journal-title":"Gastroenterology"},{"key":"ref2","article-title":"Spectrum of histopathological lesions of gallbladder","volume":"8","author":"Manu K","year":"2021","unstructured":"Manu K, Srivastava D, Singh A. Spectrum of histopathological lesions of gallbladder. IJCMR. 2021, 8:5-7.","journal-title":"IJCMR"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-016-5002-y","article-title":"Histopathological examination of specimen following cholecystectomy: are we accepting resect and discard?","volume":"31","author":"Wrenn SM","year":"2017","unstructured":"Wrenn SM, Callas PW, Abu-Jaish W. Histopathological examination of specimen following cholecystectomy: are we accepting resect and discard?. Surg Endosc. 2017, 31:586-93. 10.1007\/s00464-016-5002-y","journal-title":"Surg Endosc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel RL","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017, 67:7-30. 10.3322\/caac.21387","journal-title":"CA Cancer J Clin"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i21.2591","article-title":"Adjuvant treatment in biliary tract cancer: to treat or not to treat?","volume":"18","author":"Cereda S","year":"2012","unstructured":"Cereda S, Belli C, Reni M. Adjuvant treatment in biliary tract cancer: to treat or not to treat?. World J Gastroenterol. 2012, 18:2591-6. 10.3748\/wjg.v18.i21.2591","journal-title":"World J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s1479-666x(08)80073-x","article-title":"Gall bladder cancer - a comprehensive review","volume":"6","author":"Lai CH","year":"2008","unstructured":"Lai CH, Lau WY. Gall bladder cancer - a comprehensive review. Surgeon. 2008, 6:101-10. 10.1016\/s1479-666x(08)80073-x","journal-title":"Surgeon"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers","volume":"341","author":"de Groen PC","year":"1999","unstructured":"de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999, 341:1368-78. 10.1056\/NEJM199910283411807","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8698204","article-title":"Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression","volume":"111","author":"Roa I","year":"1996","unstructured":"Roa I, Araya JC, Villaseca M, De Aretxabala X, Riedemann P, Endoh K, Roa J. Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression. Gastroenterology. 1996, 111:232-6. 10.1053\/gast.1996.v111.pm8698204","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2016.12.009","article-title":"Intrahepatic cholangiocarcinoma: molecular markers for diagnosis and prognosis","volume":"26","author":"Rahnemai-Azar AA","year":"2017","unstructured":"Rahnemai-Azar AA, Weisbrod A, Dillhoff M, Schmidt C, Pawlik TM. Intrahepatic cholangiocarcinoma: molecular markers for diagnosis and prognosis. Surg Oncol. 2017, 26:125-37. 10.1016\/j.suronc.2016.12.009","journal-title":"Surg Oncol"},{"key":"ref10","article-title":"Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor","volume":"20","author":"Sun L","year":"2020","unstructured":"Sun L, Ji X, Wang D, et al.. Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor. BMC Cancer. 2020, 20:980.","journal-title":"BMC Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9224-4","article-title":"Incidence pattern and survival for gallbladder cancer over three decades--an analysis of 10301 patients","volume":"14","author":"Kiran RP","year":"2007","unstructured":"Kiran RP, Pokala N, Dudrick SJ. Incidence pattern and survival for gallbladder cancer over three decades--an analysis of 10301 patients. Ann Surg Oncol. 2007, 14:827-32. 10.1245\/s10434-006-9224-4","journal-title":"Ann Surg Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s005340070004","article-title":"Precancerous conditions of gallbladder carcinoma: overview of histopathologic characteristics and molecular genetic findings","volume":"7","author":"Sasatomi E","year":"2000","unstructured":"Sasatomi E, Tokunaga O, Miyazaki K. Precancerous conditions of gallbladder carcinoma: overview of histopathologic characteristics and molecular genetic findings. J Hepatobiliary Pancreat Surg. 2000, 7:556-67. 10.1007\/s005340070004","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5858\/2005-129-386-PPOGDA","article-title":"Putative precursors of gallbladder dysplasia: a review of 400 routinely resected specimens","volume":"129","author":"Mukhopadhyay S","year":"2005","unstructured":"Mukhopadhyay S, Landas SK. Putative precursors of gallbladder dysplasia: a review of 400 routinely resected specimens. Arch Pathol Lab Med. 2005, 129:386-90. 10.5858\/2005-129-386-PPOGDA","journal-title":"Arch Pathol Lab Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910450505","article-title":"Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer?","volume":"45","author":"Strom BL","year":"1990","unstructured":"Strom BL, Maislin G, West SL, et al.. Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer?. Int J Cancer. 1990, 45:821-4. 10.1002\/ijc.2910450505","journal-title":"Int J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2010.02.006","article-title":"Management of gallbladder cancer","volume":"39","author":"Jayaraman S","year":"2010","unstructured":"Jayaraman S, Jarnagin WR. Management of gallbladder cancer. Gastroenterol Clin North Am. 2010, 39:331-42. 10.1016\/j.gtc.2010.02.006","journal-title":"Gastroenterol Clin North Am"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2017.01.17","article-title":"Adjuvant therapy in biliary tract and gall bladder carcinomas: a review","volume":"8","author":"Prabhu RS","year":"2017","unstructured":"Prabhu RS, Hwang J. Adjuvant therapy in biliary tract and gall bladder carcinomas: a review. J Gastrointest Oncol. 2017, 8:302-13. 10.21037\/jgo.2017.01.17","journal-title":"J Gastrointest Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.2219","article-title":"SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"33","author":"Ben-Josef E","year":"2015","unstructured":"Ben-Josef E, Guthrie KA, El-Khoueiry AB, et al.. SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015, 33:2617-22. 10.1200\/JCO.2014.60.2219","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604047","article-title":"Gallstones and the risk of biliary tract cancer: a population-based study in China","volume":"97","author":"Hsing AW","year":"2007","unstructured":"Hsing AW, Gao YT, Han TQ, et al.. Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer. 2007, 97:1577-82. 10.1038\/sj.bjc.6604047","journal-title":"Br J Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23307","article-title":"Serum lipid levels and the risk of biliary tract cancers and biliary stones: a population-based study in China","volume":"122","author":"Andreotti G","year":"2008","unstructured":"Andreotti G, Chen J, Gao YT, et al.. Serum lipid levels and the risk of biliary tract cancers and biliary stones: a population-based study in China. Int J Cancer. 2008, 122:2322-9. 10.1002\/ijc.23307","journal-title":"Int J Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90978-a","article-title":"Serum lipids and gallstones: a case-control study","volume":"99","author":"Thijs C","year":"1990","unstructured":"Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology. 1990, 99:843-9. 10.1016\/0016-5085(90)90978-a","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2020.158737","article-title":"Adipose triglyceride lipase activity regulates cancer cell proliferation via AMP-kinase and mTOR signaling","volume":"186","author":"Xie H","year":"2020","unstructured":"Xie H, Heier C, Kien B, et al.. Adipose triglyceride lipase activity regulates cancer cell proliferation via AMP-kinase and mTOR signaling. Biochim Biophys Acta Mol Cell Biol Lipids. 2020, 186:158737. 10.1016\/j.bbalip.2020.158737","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.4103\/jcar.JCar_9_21","article-title":"Expression and clinicopathological correlation of Ki-67 in gallbladder carcinoma","volume":"20","author":"Gupta A","year":"2021","unstructured":"Gupta A, Gupta S, Rajput D, et al.. Expression and clinicopathological correlation of Ki-67 in gallbladder carcinoma. J Carcinog. 2021, 20:11.","journal-title":"J Carcinog"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.10.007","article-title":"HDL and cancer - causality still needs to be confirmed? Update 2020","volume":"73","author":"Ganjali S","year":"2021","unstructured":"Ganjali S, Banach M, Pirro M, Fras Z, Sahebkar A. HDL and cancer - causality still needs to be confirmed? Update 2020. Semin Cancer Biol. 2021, 73:169-77. 10.1016\/j.semcancer.2020.10.007","journal-title":"Semin Cancer Biol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4942","article-title":"Statins associate with lower risk of biliary tract cancers: a systematic review and meta\u2010analysis","volume":"12","author":"Cheung KS","year":"2023","unstructured":"Cheung KS, Yeung YWM, Wong WS, Li B, Seto WK, Leung WK. Statins associate with lower risk of biliary tract cancers: a systematic review and meta\u2010analysis. Cancer Med. 2023, 12:557-68. 10.1002\/cam4.4942","journal-title":"Cancer Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137476","article-title":"Associations between diabetes mellitus and selected cancers","volume":"25","author":"Pliszka M","year":"2024","unstructured":"Pliszka M, Szablewski L. Associations between diabetes mellitus and selected cancers. Int J Mol Sci. 2024, 25:7476. 10.3390\/ijms25137476","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5114\/ceh.2019.85166","article-title":"Epidemiology of gallbladder cancer","volume":"5","author":"Rawla P","year":"2019","unstructured":"Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019, 5:93-102. 10.5114\/ceh.2019.85166","journal-title":"Clin Exp Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_201_19","article-title":"Risk factors for gallbladder cancer development in northern India: a gallstones-matched, case-control study","volume":"154","author":"Mishra K","year":"2021","unstructured":"Mishra K, Behari A, Shukla P, et al.. Risk factors for gallbladder cancer development in northern India: a gallstones-matched, case-control study. Indian J Med Res. 2021, 154:699-706. 10.4103\/ijmr.IJMR_201_19","journal-title":"Indian J Med Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4021\/jocmr1689w","article-title":"Metaplastic changes in chronic cholecystitis: implications for early diagnosis and surgical intervention to prevent the gallbladder metaplasia-dysplasia-carcinoma sequence","volume":"6","author":"Seretis C","year":"2014","unstructured":"Seretis C, Lagoudianakis E, Gemenetzis G, Seretis F, Pappas A, Gourgiotis S. Metaplastic changes in chronic cholecystitis: implications for early diagnosis and surgical intervention to prevent the gallbladder metaplasia-dysplasia-carcinoma sequence. J Clin Med Res. 2014, 6:26-9. 10.4021\/jocmr1689w","journal-title":"J Clin Med Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13010028","article-title":"Oxidative stress and redox-dependent pathways in cholangiocarcinoma","volume":"13","author":"Caligiuri A","year":"2023","unstructured":"Caligiuri A, Becatti M, Porro N, et al.. Oxidative stress and redox-dependent pathways in cholangiocarcinoma. Antioxidants (Basel). 2023, 13:28. 10.3390\/antiox13010028","journal-title":"Antioxidants (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114654","article-title":"Lipoproteins and cancer: the role of HDL-C, LDL-C, and cholesterol-lowering drugs","volume":"196","author":"Patel KK","year":"2022","unstructured":"Patel KK, Kashfi K. Lipoproteins and cancer: the role of HDL-C, LDL-C, and cholesterol-lowering drugs. Biochem Pharmacol. 2022, 196:114654. 10.1016\/j.bcp.2021.114654","journal-title":"Biochem Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.09.008","article-title":"Even cancer cells watch their cholesterol!","volume":"76","author":"Riscal R","year":"2019","unstructured":"Riscal R, Skuli N, Simon MC. Even cancer cells watch their cholesterol!. Mol Cell. 2019, 76:220-31. 10.1016\/j.molcel.2019.09.008","journal-title":"Mol Cell"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/391378-serum-lipid-abnormalities-in-pre-malignant-and-malignant-lesions-of-the-gall-bladder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T16:21:02Z","timestamp":1755361262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/391378-serum-lipid-abnormalities-in-pre-malignant-and-malignant-lesions-of-the-gall-bladder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.90229","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,16]]}}}